跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
P2X7 antagonist
首页
药物
P2X7 antagonist
P2X7 antagonist
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Amino-tetrazoles analogues and methods of use
US 8217067 B2
申请人: CARROLL WILLIAM A
优先权: 2005
US
5 件公开
Pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti-inflammatory drug
US 2007082930 A1
申请人: ASTRAZENECA AB
优先权: 2003
CN
US
2 件公开
P2X7 receptor antagonists and methods of use
US 7709469 B2
申请人: ABBOTT LAB
优先权: 2005
CN
US
2 件公开
P2X7 RECEPTOR ANTAGONIST
WO 2025119390 A1
申请人: UNIV SICHUAN
优先权: 2022
CN
WO
2 件公开
N-ARYL BENZAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
EP 4777495 A1
申请人: SUVEN LIFE SCIENCES LTD
优先权: 2023
EP
WO
2 件公开
USE OF NADPH IN PREPARATION OF DRUG FOR TREATING MAJOR DEPRESSION, BIPOLAR DISORDER, POST-STROKE DEPRESSION OR NEUROINFLAMMATION
WO 2025077939 A3
申请人: SUZHOU RENBEN PHARMACEUTICAL CO LTD
优先权: 2023
CN
WO
2 件公开
Pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine
US 2007010497 A1
申请人: BOUGHTON-SMITH NIGEL
优先权: 2003
US
Pharmaceutical Composition Containing a P2x7 Receptor Antagonist and Methotrexate
US 2007281931 A1
申请人: BOUGHTON-SMITH NIGEL
优先权: 2003
US
Pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha
US 2007032465 A1
申请人: BOUGHTON-SMITH NIGEL
优先权: 2003
US
P2X7 receptor antagonists and uses thereof
CN 101304975 A
申请人: ABBOTT LAB
优先权: 2005
CN
第 1 / 2 页
上一页
下一页
药物
反馈